d'Amore, Francesco and Leppa, Sirpa and da Silva, Maria Comes and Relander, Thomas and Brown, Peter De Nully and Weidmann, Eckhart and Lauritzsen, Grete Fossum and Pezzutto, Antonio and Van Hoof, Achiel and van Gelder, Michel and Doorduijn, Jeanette K. and Wu, Ka Lung and Kluin-Nelemans, J. C. and Lugtenburg, P. J. and Jankovska, Milada and Merup, Mats and Fagerli, Unn-Merete and Walewski, Jan and Hagberg, Hans and Mariz, Jose Mario and Hansen, Per Boye and Noesslinger, Thomas and Janssens, Ann and Brandefors, Lena and Demuynck, Hilde and Schaafsma, Martyn Ronald and Christiansen, Ilse and Salek, David and Jyrkkio, Sirkku and Prochazka, Vit and Zijlstra, Josee and Bohmer, L. and Greil, Richard and Stevens, Wendy and Fijnheer, Rob and Kooy, Marinus van Marwijk and Grube, Matthias and Hopfinger, Georg and Van den Neste, Eric and Jantunen, Esa and Truemper, Lorenz and Wulf, Gerald and Altmann, Bettina and Ziepert, Marita and Loeffler, Markus and Toldbod, Helle
(2012)
First Interim Efficacy and Safety Analysis of an International Phase III Randomized Trial in Newly Diagnosed Systemic Peripheral T-Cell Lymphoma Treated with Chemotherapy with or without Alemtuzumab and Consolidated by High Dose Therapy.
BLOOD, 120 (21): 57.
ISSN 0006-4971, 1528-0020
Full text not available from this repository.
Actions (login required)
 |
View Item |
